Skip to main content
. 2012 Mar;28(3):282–288. doi: 10.1089/aid.2011.0057

Table 2.

Proportion of HIV-Infected Children Reporting Opportunistic and Other Infections Prior to Enrollment in NISDI and PACTG

 
NISDIa
PACTG 219C3
Category N=731 Percent (95% CI)b N=2767 Percent (95% CI)b
Overall first infections 568 77.7 (74.7–80.7) Not reported
Bacterial pneumonia 384 52.5 (48.9–56.2) 698 25.2 (23.6–26.8)
Oral candidiasis 212 29.0 (25.7–32.3) 761 27.5 (25.8–29.2)
Varicella 161 22.0 (19.0–25.0) 395 14.3 (13.0–15.6)
Tuberculosis 65 8.9 (6.8–11.0) 17 0.6 (0.3–0.9)
Herpes zoster 63 8.6 (6.6–10.6) 280 10.0 (9.0–11.2)
Pneumocystis jiroveci 61 8.3 (6.3–10.3) 79 2.9 (2.2–3.5)
Diarrhea, proven 56 7.7 (5.7–9.6) 104 3.8 (3.1–4.5)
Molluscum contagiosum 56 7.7 (5.7–9.6) 151 5.5 (4.6–6.3)
Abscess, bacterial 48 6.6 (4.8–8.4) 5 0.2 (0.0–0.3)
Bacteremia/septicemia 48 6.6 (4.8–8.4) 220 8.0 (6.9–9.0)
Dermatophyte infections 46 6.3 (4.5–8.1) 422 15.3 (13.9–16.6)
Urinary tract infections 44 6.0 (4.3–7.7) 68 2.5 (1.9–3.0)
Lymphadenitis 40 5.5 (3.8–7.1) 11 0.4 (0.2–0.6)
Lymphoid interstitial pneumonitis 39 5.3 (3.7–7.0) 325 11.8 (10.6–13.0)
Herpes simplex 27 3.7 (2.3–5.1) 24 0.9 (0.5–1.2)
Bacterial meningitis 23 3.1 (1.9–4.4) 13 0.5 (0.2–0.7)
Viral hepatitis 15 2.1 (1.0–3.1) 60 2.2 (1.6–2.7)
Cytomegalovirus not retinitis 11 1.5 (0.6–2.4) 49 1.8 (1.3–2.3)
Esophageal/pulmonary candidiasis 10 1.4 (0.5–2.2) 39 1.4 (1.0–1.9)
Toxoplasmosis (CNS) 9 1.2 (0.4–2.0) 5 0.2 (0.0–0.3)
Cytomegalovirus retinitis 6 0.8 (0.2–1.5) 10 0.4 (0.1–0.6)
Measles 5 0.7 (0.1–1.3) 5 0.2 (0.0–0.3)
a

NISDI also reported three cases of progressive multifocal leukoencephalopathy, two cases of bacterial osteomyelitis, and one each of Cryptosporidium and encephalitis.

b

Higher reporting of specific infections between cohorts shown by bolded nonoverlapping intervals.